DMD and Duchenne muscular dystrophy: The study further revealed that compared to microdystrophin therapy for DMD, full-length dystrophin effectively restores the sarcolemmal localization of cavin-4 while concomitantly mitigating aberrant activation of the associated ERK1/2 signaling pathway.